부산대학교 도서관

Criscitiello C; Viale G; Curigliano G; Goldhirsch A

Breast Cancer: Targets and Therapy, Vol 10, Pp 23-29 (2018)

Rüschoff J; Viale G

Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Electronic Cited Medium: Internet ISSN: 1543-2165 (Electronic) Linking ISSN: 00039985 NLM ISO Abbreviation: Arch Pathol Lab Med Subsets: MEDLINE; In Process

Vainer GW; Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; Badve SS; Emory Winship Cancer Institute, Atlanta, GA, United States.; Rajadurai P; Monash University Malaysia, Selangor, Malaysia Subang Jaya Medical Centre, Subang Jaya, Malaysia.; Soares FA; Instituto de Anatomia Patológica, Rede D'Or São Luiz, São Paulo, Brazil.; Instituto de Pesquisa e Ensino D'Or, São Paulo, Brazil.; Viale G; IEO, European Institute of Oncology IRCCS, Milan, Italy.; Büttner R; University of Cologne Medical Faculty, Cologne, Germany.; Nuti S; Merck & Co., Inc., Rahway, NJ, United States.; Juco J; Merck & Co., Inc., Rahway, NJ, United States.; Krishnan R; Merck & Co., Inc., Rahway, NJ, United States.; Tsao MS; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

O'Regan RM; Department of Medicine, University of Rochester, Rochester, New York.; Ren Y; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zhang Y; Biotheranostics, A Hologic Company, San Diego, California.; Siuliukina N; Biotheranostics, A Hologic Company, San Diego, California.; Schnabel CA; Biotheranostics, A Hologic Company, San Diego, California.; Kammler R; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Viale G; International Breast Cancer Study Group Central Pathology Office, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; Dell'Orto P; International Breast Cancer Study Group Central Pathology Office, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; Munzone E; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Láng I; Clinexpert-Research, Budapest, Hungary.; Tondini C; Ospedale Papa Giovanni XXIII, Bergamo, Italy.; Gomez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; Chini C; Deaprment of Medical Oncology, Azienda Socio Sanitaria Territoriale dei Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.; Nicoletti SVL; Department of Medical Oncology, Ospedale Infermi Rimini, Ausl Romagna, Italy.; Puglisi F; Department of Medicine, University of Udine, Udine, Italy.; Department of Medical Oncology, National Cancer Institute, Centro di Riferimento Oncologico, IRCCS, Aviano, Pordenone, Italy.; Zaman K; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Department of Medical Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Goetz MP; Mayo Clinic Department of Oncology, and Alliance for Clinical Trials in Oncology, Rochester, Minnesota.; Stearns V; Meyer Cancer Center, Weill Cornell Medicine, New York.; Martino S; The Angeles Clinic and Research Institute, Santa Monica, California.; SWOG Cancer Research Network, San Antonio, Texas.; Salim M; Allan Blair Cancer Center, Regina, Saskatchewan, Canada.; Loibl S; German Breast Group Forschungs GmbH, Neu-Isenburg, Germany.; Goethe University, Frankfurt am Main, Germany.; Geyer CE; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.; NSABP Foundation, NRG Oncology, Pittsburgh, Pennsylvania.; Bonnefoi HR; Institut Bergonié, Université de Bordeaux Collège Sciences de la santé, INSERM U1312, Bordeaux, France.; European Organization for Research and Treatment of Cancer, Brussels, Belgium.; Ciruelos EM; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Loi S; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne Australia.; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Colleoni M; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Fleming GF; The University of Chicago Medical Center, Chicago, Illinois.; Francis PA; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia.; St Vincent's Hospital, Melbourne, Australia.; Breast Cancer Trials Australia and New Zealand, Newcastle, Australia.; Walley BA; University of Calgary, Calgary, Alberta, Canada.; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Pagani O; Geneva University Hospitals, Geneva, Switzerland.; Lugano University, Lugano, Switzerland.; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Treuner K; Biotheranostics, A Hologic Company, San Diego, California.; Regan MM; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Balko JM; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. justin.balko@vumc.org.; Licata L; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Wang XQ; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Dugo M; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Huang CS; National Taiwan University Hospital and College of medicine, National Taiwan University, Taipei, Taiwan.; Egle D; Department of Gynecology, Medical University Innsbruck, Innsbruck, Austria.; Bermejo B; Medical Oncology, Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain.; Medicine Department, Universidad de Valencia, Valencia, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain.; Zamagni C; IRCCS Azienda Ospedaliero-universitaria di Bologna, Municipality, Italy.; Thill M; Department of Gynecology and Gynecological Oncology Agaplesion Markus Krankenhaus, Frankfurt, Germany.; Anton A; Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IISA), Universidad de Zaragoza, Zaragoza, Spain.; Russo S; Department of Oncology, Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy.; Sevillano E; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), Laboratorio de Innovación en Oncología, Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain.; Ciruelos EM; Hospital Universitario 12 de Octubre, Madrid, Spain.; Greil R; Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, Cancer Cluster Salzburg, Salzburg, Austria.; Semiglazov V; N. N. Petrov Research Institute of Oncology, St. Petersburg, Russian Federation.; Colleoni M; Division of Medical Senology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Kelly CM; Department of Medical Oncology, Mater Private Hospital, Dublin, Ireland.; Mariani G; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Del Mastro L; Clinical Oncology Unit; IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Specialties; Università di Genova, Genova, Italy.; Zambelli S; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Viale G; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Callari M; Fondazione Michelangelo, Milan, Italy.; Viale G; Department of Pathology & Laboratory Medicine, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Gianni L; International Breast Cancer Research Committee-Fondazione Michelangelo, Milan, Italy.; Ali HR; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Bianchini G; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Università Vita-Salute San Raffaele, Milan, Italy.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Aurilio G; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.; Serrano D; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.; Lazzeroni M; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.; Guerrieri-Gonzaga A; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.; Johansson H; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.; Gandini S; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Briata IM; E.O. Galliera Hospital, Genoa, Italy.; D'Amico M; E.O. Galliera Hospital, Genoa, Italy.; Spinaci S; Ospedale Villa Scassi ASL3, Genoa, Italy.; Veronesi P; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Galimberti V; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.; Intra M; Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.; Heckman-Stoddard BM; Division of Cancer Prevention, NCI, Bethesda, MD, USA.; Szabo E; Division of Cancer Prevention, NCI, Bethesda, MD, USA.; Viale G; Division of Pathology, IEO European Institute of Oncology IRCCS, Milan, Italy.; University of Milan, Milan, Italy.; Bonanni B; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.; DeCensi A; E.O. Galliera Hospital, Genoa, Italy. andrea.decensi@galliera.it.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Tung N; Cancer Risk and Prevention Program and Breast Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, United States.; Hollis RL; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.; Viale G; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy.; Tweed C; Maryland Oncology Hematology, Annapolis, MD, United States.; Lukashchuk N; Oncology R&D, Translational Medicine, AstraZeneca, Cambridge, United Kingdom.; Birrer M; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, United States.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Persano I; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: persano.irene@hsr.it.; Licata L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: licata.luca@hsr.it.; Piras M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: piras.marta@hsr.it.; Ata-Shiroshita A; Department of Surgery, Division of Breast Surgery Showa Medical University, 1-5-8 Hatanodai Shinagawa-ku Tokyo 142-8555 Japan. Electronic address: ataarisa19880902@gmail.com.; Naldini MM; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy. Electronic address: naldini.matteomaria@hsr.it.; Bosi C; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy. Electronic address: bosi.carlo@hsr.it.; Notini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: 3notini.giulia@hsr.it.; Mariani M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: 3mariani.marco@hsr.it.; Chiavassa A; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy. Electronic address: chiavassa.antonella@hsr.it.; Patanè F; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy; Department of Oncology, University Hospital of Pisa, Pisa, Italy. Electronic address: patane.francesca@hsr.it.; Zanibelli C; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy. Electronic address: zanibelli.caterina@hsr.it.; Rognone A; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: rognone.alessia@hsr.it.; Sica L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: sica.lorenzo@hsr.it.; Zambelli S; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: zambelli.stefania@hsr.it.; Zucchinelli P; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: zucchinelli.patrizia@hsr.it.; Guarino A; Department of Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy. Electronic address: guarino.alessandra@hsr.it.; Pasetti M; Department of Radiotherapy, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: pasetti.marcella@hsr.it.; Di Micco R; Breast Surgery Unit, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: dimicco.rosa@hsr.it.; Gentilini OD; Università Vita-Salute San Raffaele, Milan, Italy; Breast Surgery Unit, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: gentilini.oreste@hsr.it.; Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy. Electronic address: bianchini.giampaolo@hsr.it.; Viale G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy. Electronic address: viale.giulia@hsr.it.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

Malorni L; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy. Electronic address: luca.malorni@uslcentro.toscana.it.; Tyekucheva S; International Breast Cancer Study Group Statistical Center, Department of Data Science, Dana-Farber Cancer Institute, Boston, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, USA.; Gombos A; Institut Jules Bordet, Hôpital Universitaire de Bruxelles and Université Libre de Bruxelles, Brussels, Belgium.; Hasler-Strub U; Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland; Department of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.; Zamagni C; IRCCS Azienda ospedaliero-universitaria di Bologna, Bologna, Italy.; Chakiba-Brugère C; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.; Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.; Mueller A; Department of Medical Oncology, KSW Cantonal Hospital Winterthur, Winterthur, Switzerland.; Minisini AM; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Taylor D; Department of Oncology, CHU UCL Namur-Site Sainte-Elisabeth, Namur, Belgium.; Salmon JP; Department of Medical Oncology, CHR Citadelle, Liege, Belgium.; Gallerani E; Department of Oncology, ASST Sette Laghi, Varese, Italy.; Cariello A; Department of Oncology, AUSL Romagna, Ospedale Santa Maria delle Croci, Ravenna, Italy.; Fontana A; Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Roschitzki-Voser H; ETOP IBCSG Partners Foundation, Coordinating Center, Bern, Switzerland.; Kammler R; Translational Research Coordination, ETOP IBCSG Partners Foundation, Coordinating Center, Bern, Switzerland.; Ruepp B; ETOP IBCSG Partners Foundation, Coordinating Center, Bern, Switzerland.; Loi S; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne, Australia; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Viale G; IEO European Institute of Oncology IRCCS, Milan, Italy.; Regan MM; International Breast Cancer Study Group Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA.; Brain E; Department of Medical Oncology, Institut Curie, Saint Cloud, France.; Biganzoli L; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

O'Regan RM; Department of Medicine, University of Rochester, Rochester, NY, USA.; Ren Y; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA.; Zhang Y; Biotheranostics, A Hologic Company, San Diego, CA, USA.; Fleming GF; The University of Chicago Medical Center, Chicago, IL, USA.; Francis PA; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, VIC, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre Melbourne, VIC, Australia; St Vincent's Hospital, Melbourne, Australia; Breast Cancer Trials Australia & New Zealand, Newcastle, Australia.; Pagani O; Geneva University Hospitals, Geneva, Switzerland; Lugano University, Lugano, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Walley BA; University of Calgary, Calgary, AB, Canada; Canadian Cancer Trials Group (CCTG), Queen's University, Kingston, ON, Canada.; Kammler R; Translational Research Coordination, International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Dell'Orto P; IBCSG Central Pathology Office, Milan, Italy; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; Viale G; IBCSG Central Pathology Office, Milan, Italy; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; Loi S; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, VIC, Australia; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; Colleoni M; Division of Medical Senology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Treuner K; Biotheranostics, A Hologic Company, San Diego, CA, USA.; Regan MM; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: mregan@jimmy.harvard.edu.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Esposito A; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Marra A; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.; Frassoni S; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.; Morganti S; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Viale G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Zagami P; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Varano GM; Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Buccimazza G; Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milano, Milan, Italy.; Orsi F; Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Venetis K; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Mazzarella L; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, Milan, Italy.; Viale G; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Fusco N; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Criscitiello C; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Curigliano G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE; In Process

Rüschoff J; From the Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany (Rüschoff, Penner, Baenfer, Schildhaus).; Penner A; From the Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany (Rüschoff, Penner, Baenfer, Schildhaus).; Ellis IO; Translational Medical Sciences, School of Medicine, The University of Nottingham, Department of Histopathology, City Hospital Campus, Nottingham University Hospitals, Nottingham, United Kingdom (Ellis).; Hammond MEH; Department of Pathology, Intermountain Healthcare and University of Utah School of Medicine, Salt Lake City (Hammond).; Lebeau A; University Medical Center Hamburg-Eppendorf, Institute of Pathology, Hamburg, Germany (Lebeau).; Private Group Practice for Pathology, Lübeck, Germany (Lebeau).; Osamura RY; Department of Diagnostic Pathology, Nippon Koukan Hospital, Kawasaki, Japan (Osamura).; Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France (Penault-Llorca).; Rojo F; Department of Pathology, IIS-Hospital Universitario Fundacion Jimenez Diaz-CIBERONC, Madrid, Spain (Rojo).; Desai C; Daiichi Sankyo, Basking Ridge, New Jersey (Desai, Moh).; Moh A; Daiichi Sankyo, Basking Ridge, New Jersey (Desai, Moh).; Atkey N; Diaceutics plc, Dataworks at Kings Hall Life Sciences Park, Belfast, County Antrim, United Kingdom (Atkey).; Baenfer G; From the Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany (Rüschoff, Penner, Baenfer, Schildhaus).; Scheel AH; Department of Pathology, University of Cologne, Cologne, Germany (Scheel).; D'Arrigo C; Poundbury Cancer Institute, Dorchester, United Kingdom (D'Arrigo).; Schildhaus HU; From the Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany (Rüschoff, Penner, Baenfer, Schildhaus).; Viale G; Department of Pathology, IEO European Institute of Oncology IRCCS Milan, Italy (Viale).

Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet ISSN: 1543-2165 (Electronic) Linking ISSN: 00039985 NLM ISO Abbreviation: Arch Pathol Lab Med Subsets: MEDLINE

Conforti F; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo, Italy; Humanitas University, Rozzano, Italy. Electronic address: fabio.conforti1984@gmail.com.; Holtschmidt J; German Breast Group (GBG) Forschungs, Neu-Isenburg, Germany.; Nekljudova V; German Breast Group (GBG) Forschungs, Neu-Isenburg, Germany.; Sala I; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.; Pagan E; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.; Solbach C; University Hospital Frankfurt, Frankfurt, Germany.; Untch M; Helios Kliniken, Berlin-Buch, Germany.; Denkert C; Institute of Pathology, Philipps-University Marburg, University Hospital UKGM Marburg, Germany.; Bagnardi V; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.; Pala L; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo, Italy.; Fasching PA; University Hospital Erlangen, Erlangen, Germany.; Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.; Lück HJ; Gynecologic Oncology Practice, Neumarkt, Germany.; Viale G; Department of Pathology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.; De Pas T; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo, Italy.; van Mackelenbergh M; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Schleswig-Holstein, Germany.; Huober J; Cantonal Hospital, Breast Center St Gallen, St Gallen, Switzerland.; Müller V; University Medical Center Hamburg-Eppendorf, Hamburg-Eppendorf, Germany.; Link T; Department of Gynecology and Obstetrics, Technical University Dresden, Dresden, Germany.; Karn T; Department of Obstetrics and Gynecology, University Hospital Frankfurt, Frankfurt, Germany.; Reinisch M; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.; Marmé F; Department of Obstetrics and Gynecology, Medical Faculty Mannheim, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.; Bjelic-Radisic V; Breast Unit, University Hospital Helios, University Witten Herdecke, Wuppertal, Germany.; Schem C; Breast Center Hamburg, Hamburg, Germany.; Hartkopf A; AGO Study Group and University Hospital Tübingen, Tübingen, Germany.; Stickeler E; Department of Obstetrics and Gynecology, University Hospital of RWTH Aachen, Aachen, Germany.; Hanusch C; Rotkreuzklinikum Munich, Munich, Germany.; Blohmer JU; Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.; Fehm T; University Hospital Düsseldorf, Düsseldorf, Germany.; Rhiem K; Center for Familial Breast and Ovarian Cancer, University of Cologne, Cologne, Germany.; Gelber R; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science and Technology Research Foundation, Boston, MA, USA.; Loibl S; German Breast Group (GBG) Forschungs, Neu-Isenburg, Germany.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Berton Giachetti PPM; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Morganti S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Gandini S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Giudici F; Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano IRCCS, Aviano, Italy.; Marra A; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Nicolò E; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, New York.; Zattarin E; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Corti C; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Boldrini L; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Verrazzo A; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Pascale, Naples, Italy.; Sposetti C; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Razeti MG; Department of Internal Medicine and Medical Sciences, School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Carnevale Schianca A; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Scafetta R; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Roma, Italy.; Taurelli Salimbeni B; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Esposito A; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Zagami P; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Trapani D; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Malagutti B; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; Caputo R; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Pascale, Naples, Italy.; Vernieri C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Munzone E; Division of Medical Senology, Research Unit in Medical Senology, European Institute of Oncology IRCCS, Milan, Italy.; Scagnoli S; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy.; Botticelli A; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy.; Lambertini M; Department of Internal Medicine and Medical Sciences, School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Giuliano M; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.; De Laurentiis M; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Pascale, Naples, Italy.; Viale G; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Bianchini G; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Curigliano G; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.; De Angelis C; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.; Criscitiello C; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Cursano G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Concardi A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Ivanova M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Frascarelli C; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Mane E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Mangione E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Santaguida S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Tosoni D; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Pece S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Marra A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy. Konstantinos.venetis@ieo.it.; Rocco EG; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Fusco N; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE

Schildhaus HU; Department of Pathology and Medical Affairs Department, Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany.; Badve S; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.; D'Arrigo C; Department of Histopathology, Poundbury Cancer Institute, Dorchester, UK.; Farshid G; Department of SA Pathology, Royal Adelaide Hospital, Adelaide, Australia.; Lebeau A; Department of Pathology, Institute of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Peg V; Department of Pathology, University Hospital Vall d'Hebron, Barcelona, Spain.; Penault-Llorca F; Department of Pathology, Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France.; Rüschoff J; Department of Pathology and Medical Affairs Department, Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany.; Yang W; Department of Pathology, Fudan University, Shanghai Cancer Center, Shanghai, China.; Atkey N; Department of Scientific Services, Diaceutics PLC, Belfast, UK.; Lauer C; Department of Biostatistics & Data Management, Daiichi Sankyo Europe GmbH, Munich, Germany.; Baumann J; Department of Global Oncology Diagnostics, AstraZeneca, Gaithersburg, Maryland.; Beyerlein E; Department of Biostatistics & Data Management, Daiichi Sankyo Europe GmbH, Munich, Germany.; Newell AH; Department of Clinical Operations, Daiichi Sankyo Inc, Basking Ridge, New Jersey.; Penner A; Department of Pathology and Medical Affairs Department, Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany.; Moh A; Department of Clinical Operations, Daiichi Sankyo Inc, Basking Ridge, New Jersey.; Viale G; Department of Pathology & Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy. Electronic address: giuseppe.viale@ieo.it.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

Botticelli A; Medical Oncology Unit B, Policlinico Umberto I, 00161 Rome, Italy.; Brignoli O; Fondazione SIMG, SIMG-Italian Society of General Medicine, 50142 Firenze, Italy.; Caruso F; Breast Unit, Humanitas Istituto Clinico Catanese, SP54, Contrada Cubba Marletta, 11, 95045 Misterbianco, Italy.; Curigliano G; European Institute of Oncology IRCCS, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, 20133 Milan, Italy.; Di Lauro V; Department of Breast & Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131 Naples, Italy.; Masini C; Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.; Taffurelli M; Senonetwork Italia, 63822 Florence, Italy.; Viale G; European Institute of Oncology, 20141 Milan, Italy.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Licata L; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; Mariani M; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.; Viale G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; Dent R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Schmid P; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Hamilton E; Medical Oncology, Sarah Cannon Research Institute, Nashville, Tennessee.; Sotiriou C; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Giugliano F; INSERM U981, Gustave Roussy, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Oncology and Hematology-Oncology, University of Milano, Milan, Italy.; De Angelis C; Clinical and Translational Oncology, Scuola Superiore Meridionale Via Mezzocannone, 4 80134 Naples, Italy.; Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, France; INSERM U1279, Gustave Roussy, Villejuif, France.; Viale G; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Bianchini G; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Giuliano M; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.; Malorni L; Translational Research Unit, Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.; Taurelli Salimbeni B; European Institute of Oncology, IRCCS, Milan, Italy.; Esposito A; European Institute of Oncology, IRCCS, Milan, Italy.; Giordano A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.; Yap TA; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer, Houston, USA.; Curigliano G; Department of Oncology and Hematology-Oncology, University of Milano, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy.; Criscitiello C; Department of Oncology and Hematology-Oncology, University of Milano, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: carmen.criscitiello@ieo.it.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

Rediti M; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Venet D; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Joaquin Garcia A; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Maetens M; Laboratory for Translational Breast Cancer Research, KU Leuven, Leuven, Belgium.; Vincent D; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Majjaj S; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; El-Abed S; Breast International Group, Brussels, Belgium.; Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Ueno T; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Izquierdo M; Novartis Pharma AG, Basel, Switzerland.; Piccart M; Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Pusztai L; Yale School of Medicine, Yale Cancer Center, New Haven, CT, USA.; Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, VIC, Australia.; Salgado R; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Rothé F; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. christos.sotiriou@hubruxelles.be.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE